Dividend
-
-
-
-
-
-
-
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
-
-
-
-
-
-
-
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
-
-
-
-
-
-
-
QIAGEN to complete $500 million synthetic share repurchase by January 7
-
-
-
-
-
-
-
European shares hit by Daimler warning, weak economic data
-
-
448,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

